Selank
An anxiolytic peptide registered as a medicine in Russia. Neither the FDA nor the EMA has approved it.
Calorize — peptide protocol & nutrition tracker
This substance has no FDA or EMA authorisation and is not a medicine. It is sold as a research reagent, which means the purity and the actual content of what is sold under this name are guaranteed by no one. Its use in humans has not been established as safe.
Not approved by either the FDA or the EMA. Registered as a medicine only in a few post-Soviet countries.
Every figure on this page is a dose reported in published sources. It is reference information, not a recommendation and not a protocol to follow. Any decision about injecting is one to make with a doctor.
Medical disclaimerWhat is Selank?
A synthetic analogue of tuftsin, a regulatory peptide. It is described as an anxiolytic without sedation, which is why the texts call it a daytime one.
The important part is its standing: in Russia, Selank is registered by the health ministry as a medicine. Neither the FDA nor the EMA has approved it, so outside a few post-Soviet countries it is an unregistered substance.
What follows is dosing arithmetic and numeric protocols drawn from published sources and clinical trials. It describes what those sources report; it is not medical advice and not instructions for use. This part of the page is meant for people aged 18 and over.
The confirmation is kept in this browser, and on the account for signed-in users. The peptide description and its regulatory status are available without it.
What follows is dosing arithmetic and numeric protocols drawn from published sources and clinical trials. It describes what those sources report; it is not medical advice and not instructions for use. This part of the page is meant for people aged 18 and over.
The confirmation is kept in this browser, and on the account for signed-in users. The peptide description and its regulatory status are available without it.
Biohacking runs on data. Body chemistry is half of it; fuel is the other half.
Start Tracking Macros